Bioventus Inc. insider trading

BVSNASDAQ

$13.13-0.32 (-2.38%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+95.7%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Unlock quarterly net flow

Key players

MPMartin P. SutterDirector19.2355%of company
JAJohn A. BartholdsonDirector10.3232%of company
WAWilliam A. HawkinsDirector0.4358%of company
MLMark Leonard SingletonSVP & CFO0.2596%of company
ADAnthony D'AdamioSVP & General Counsel0.225%of company
GPGuy P. NohraDirector0.218%of company
SMSusan M. StalneckerDirector0.2024%of company
RERobert E. ClaypoolePresident and CEO0.199%of company
GJGuido J. NeelsDirector0.1721%of company
MKMary Kay LadoneDirector0.1629%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
BVS	Michelle McMurry-HeathDirector	Open market sell$105K	-21.1%	$8.79	$105K	Mar 11, 2026	Mar 13, 2026
BVS	Guy P. NohraDirector	Open market sell$75.7K	-7.9%	$7.57	$75.7K	Dec 4, 2025	Dec 8, 2025
BVS	Michelle McMurry-HeathDirector	Open market sell$131K	-23.7%	$7.42	$131K	Nov 7, 2025	Nov 10, 2025

End of history · 3 transactions